Starting Year: 2020
Title: CLARIFY – Cancer Long Survivors Artificial Intelligence Follow Up
Abstract: The number of cancer survivors has increased in recent years due to advances in diagnoses and treatment. Ensuring post-treatment quality of life of survivors remains a challenge. The EU-funded CLARIFY project will identify the risk factors for deterioration in a patient at the end of oncological treatment. Specifically, it will collect data about survivors from breast, lung and lymphoma cancer (the most prevalent types) from hospitals in Spain. Using big data and artificial intelligence techniques, it will integrate all data with relevant publicly available biomedical information, as well as information from wearable devices used after the treatment. The data will be analysed to predict patient-specific risk of developing secondary effects and toxicities from their cancer treatments.
Funding Source: Horizon 2020 (EU)
Typology: R&D Project
Reference: 875160
Principal Investigator (PI): Mariano Provencio
PI’s institution: Servicio Madrileno de Salud
NOVA Math members involved: Gracinda Rita Guerreiro